Date | Company Name | Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|---|
Jun 7, 2022 | Code Biotherapeutics | Series A | — | Biotechnology | — |
Dec 22, 2021 | Gennao Bio | Series A | — | Biotechnology | Yes |
Aug 5, 2021 | Pepgen | Series Unknown | — | Biotechnology | — |
Apr 20, 2021 | Code Biotherapeutics | Seed | — | Biotechnology | — |
Mar 31, 2021 | Entrada Therapeutics | Series B | — | Biotechnology | — |
Dec 9, 2020 | Pepgen | Series A | — | Biotechnology | — |
Dec 8, 2020 | Edgewise Therapeutics | Series C | — | Biopharma | — |
Nov 10, 2020 | Mesentech | Series Unknown | — | Biotechnology | — |
Apr 23, 2020 | Myosana Therapeutics | Seed | — | Biotechnology | Yes |
Nov 13, 2019 | Avidity Biosciences | Series C | — | Biotechnology | — |
Nov 6, 2019 | Shape Therapeutics | Series A | — | Biotechnology | — |
Sep 17, 2019 | Edgewise Therapeutics | Series B | — | Biopharma | — |
Sep 5, 2018 | 4D Molecular Therapeutics | Series B | — | Biotechnology | — |
Feb 27, 2017 | Exonics Therapeutics | Seed | — | Biopharma | Yes |
Dec 19, 2016 | Trinds | Series Unknown | — | Market Research | Yes |
Feb 3, 2015 | Capricor Therapeutics | Post-IPO Equity | — | Biotechnology | — |